Business

NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026

EDEN PRAIRIE, MINN. - May 28, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological di...

articleNeuroone Medical Technologies CorporationMay 28, 20265/company/neuroone-medical-technologies-corp/news/neurooner-to-present-at-the-2026-american-society-for-stereotactic-and-functional-neurosurgery-biennial-meeting-on-may-31-2026
NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026

About this update from Neuroone Medical Technologies Corporation

[{"type":"image","caption":"","headline":"NeuroOne(R) to Present at the 2026 American Society for Stereotactic and Functional Neurosurgery Biennial Meeting on May 31, 2026","size":{"original":{"width":140,"height":70,"url":"https://media.zenfs.com/en/newsmediawire_165/6e29368af07e7c003454bc6560423ba4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/mO0.S9ZzO4sUF2xxFN6OXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEwNQ--/https://media.zenfs.com/en/newsmediawire_165/6e29368af07e7c003454bc6560423ba4","width":140,"height":70},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/mO0.S9ZzO4sUF2xxFN6OXQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTEwNQ--/https://media.zenfs.com/en/newsmediawire_165/6e29368af07e7c003454bc6560423ba4","width":140,"height":70}}},{"type":"text","content":"EDEN PRAIRIE, MINN. - May 28, 2026 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological disorders, today announced its participation in the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Biennial Meeting taking place May 30-June 2, 2026, at the Hilton Cleveland Downtown.","length":479,"tagName":"p"},{"type":"text","content":"NeuroOne will present the recently 510(k)-cleared OneRF(R) Trigeminal Nerve Ablation System for use in procedures to create radiofrequency lesions for the treatment of (chronic facial) pain, or for lesioning nerve tissue for functional neurosurgical procedures. The OneRF(R) Trigeminal Nerve Ablation System features an innovative multi-contact RF probe designed to enable precise mapping and ablation in fewer cycles without repositioning. This system uses the OneRF(R) Generator and may allow for reduced procedural time and improved patient comfort. The company recently announced the completion of the limited market release of its OneRF(R) Trigeminal Nerve Ablation System.","length":678,"tagName":"p"},{"type":"text","content":"The Company will also share details on its SEEG-Drug Delivery System*. This device is being developed for use in investigational studies in humans and for research in laboratory animals. Select features being designed include:","length":226,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Deliver drugs, record, and stimulate...

More updates from Neuroone Medical Technologies Corporation

Trigeminal NerveRadiofrequency AblationNeuroOne Medical Technologies CorporationThe companyradiofrequency lesionssurgical proceduresSystemforward-looking statements